- Report
- October 2024
- 198 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- September 2022
- 102 Pages
Global
From €3500EUR$3,944USD£3,043GBP
The Fixed Dose Device (FDD) market is a subset of the needles and syringes market. FDDs are pre-filled syringes and auto-injectors that are designed to deliver a specific dose of medication. They are used to treat a variety of conditions, including chronic diseases, allergies, and autoimmune disorders. FDDs are becoming increasingly popular due to their convenience and accuracy. They are also more cost-effective than traditional syringes and needles, as they require fewer components and less time to assemble.
FDDs are available in a variety of sizes and shapes, and can be tailored to meet the needs of different patients. They are also designed to be user-friendly, with features such as easy-to-read labels and audible instructions.
Some of the major players in the FDD market include Becton Dickinson, Novo Nordisk, Sanofi, and Ypsomed. Other companies include Amgen, Eli Lilly, Merck, and Pfizer. Show Less Read more